References
- MüLler B, White JC, NyléN E, et al. Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis. J Clin Endocrinol Metab. 2001;86(1):396–404. doi:10.1210/jcem.86.1.7089
- Lippi G, Sanchis-Gomar F. Procalcitonin in inflammatory bowel disease: drawbacks and opportunities. World J Gastroenterol. 2017;23(47):8283–8290. doi:10.3748/wjg.v23.i47.8283
- Schuetz P, Raad I, Amin DN. Using procalcitonin-guided algorithms to improve antimicrobial therapy in ICU patients with respiratory infections and sepsis. Curr Opin Crit Care. 2013;19(5):453–460. doi:10.1097/MCC.0b013e328363bd38
- Schuetz P, Wirz Y, Sager R, et al. Effect of procalcitonin-guided antibiotic treatment on mortality in acute respiratory infections: a patient level meta-analysis. Lancet Infect Dis. 2018;18(1):95–107. doi:10.1016/s1473-3099(17)30592-3
- de Jong E, van Oers JA, Beishuizen A, et al. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial. Lancet Infect Dis. 2016;16(7):819–827. doi:10.1016/s1473-3099(16)00053-0
- Schuetz P, Beishuizen A, Broyles M, et al. Procalcitonin (PCT)-guided antibiotic stewardship: an international experts consensus on optimized clinical use. Clin Chem Lab Med. 2019;57(9):1308–1318. doi:10.1515/cclm-2018-1181
- Assicot M, Gendrel D, Carsin H, et al. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet. 1993;341(8844):515–518. doi:10.1016/0140-6736(93)90277-n
- Meisner M. Update on procalcitonin measurements. Ann Lab Med. 2014;34(4):263–273. doi:10.3343/alm.2014.34.4.263
- Wu SC, Liang CX, Zhang YL, et al. Elevated serum procalcitonin level in patients with chronic kidney disease without infection: a case-control study. J Clin Lab Anal. 2020;34(2). doi:10.1002/jcla.23065
- Sun Y, Jiang L, Shao X. Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage. Int Urol Nephrol. 2017;49(12):2205–2216. doi:10.1007/s11255-017-1710-z
- Park JH, Kim DH, Jang HR, et al. Clinical relevance of procalcitonin and C-reactive protein as infection markers in renal impairment: a cross-sectional study. Crit Care. 2014;18(6). doi:10.1186/s13054-014-0640-8
- Lee WS, Kang DW, Back JH, et al. Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients. Korean J Intern Med. 2015;30(2):198–204. doi:10.3904/kjim.2015.30.2.198
- Herget-Rosenthal S, Marggraf G, Pietruck F, et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol Dial Transplant. 2001;16(5):975–979. doi:10.1093/ndt/16.5.975
- Meisner M, Lohs T, Huettemann E, et al. The plasma elimination rate and urinary secretion of procalcitonin in patients with normal and impaired renal function. Eur J Anaesthesiol. 2001;18(2):79–87. doi:10.1046/j.0265-0215.2000.00783.x
- Meisner M, Schmidt J, Huttner H, et al. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med. 2000;26:S212–S216. doi:10.1007/s001340051146
- Kubo S, Iwasaki M, Horie M, et al. Biological variation of procalcitonin levels in hemodialysis patients. Clin Exp Nephrol. 2019;23(3):402–408. doi:10.1007/s10157-018-1639-2
- Rasmussen TA, Sogaard OS, Camara C, et al. Serum procalcitonin in pulmonary tuberculosis. Int J Tuberc Lung Dis. 2011;15(2):251–256.
- Ugajin M, Miwa S, Shirai M, et al. Usefulness of serum procalcitonin levels in pulmonary tuberculosis. Eur Respir J. 2011;37(2):371–375. doi:10.1183/09031936.00011910
- Huang CT, Lee LN, Ho CC, et al. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis. J Infect. 2014;68(5):440–447. doi:10.1016/j.jinf.2013.12.012
- Huang SL, Lee HC, Yu CW, et al. Value of procalcitonin in differentiating pulmonary tuberculosis from other pulmonary infections: a meta-analysis. Int J Tuberc Lung Dis. 2014;18(4):470–477. doi:10.5588/ijtld.13.0449
- Soderblom T, Nyberg P, Teppo AM, et al. Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy. Eur Respir J. 1996;9(8):1652–1655. doi:10.1183/09031936.96.09081652
- Ribera E, Ocana I, Martinezvazquez JM, et al. High-level of interferon-gamma in tuberculous pleural effusion. Chest. 1988;93(2):308–311. doi:10.1378/chest.93.2.308
- England JT, Del Vecchio MT, Aronoff SC. Use of serum procalcitonin in evaluation of febrile infants: a meta-analysis of 2317 patients. J Emerg Med. 2014;47(6):682–687. doi:10.1016/j.jemermed.2014.07.034